The FDA Grants Owlet Marketing Clearance for its BabySat Monitoring Solution
Limited to physician-issued prescriptions, the BabySat is Owlet's first FDA-Cleared product; additional details will be released by the company at a later date, with sales expected to begin before 2024.
As expected by this author, Lehi, Utah-based Owlet (NYSE:OWLT) has received notice from the U.S. Food
